This tool computes the maximum safe single dose of lidocaine, bupivacaine, ropivacaine, or mepivacaine from a patient's body weight, plain or with a vasoconstrictor, to help avoid local anesthetic systemic toxicity (LAST). Not every figure in local anesthetic dosing carries the same level of source confidence — this article explains which numbers are FDA-label facts and which are conservative, hedged estimates, and why that distinction matters.
Why the four agents' caps differ in source confidence
Lidocaine's ceilings (300 mg plain, 500 mg with epinephrine) and its mg/kg rates (4.5 and 7.0 mg/kg) are explicit numbers from the FDA-approved prescribing information. Bupivacaine's absolute ceilings (175 mg plain, 225 mg with epinephrine) are also FDA-label, but the commonly-quoted mg/kg rates (2.5 and 3.0 mg/kg) are anesthesia-textbook estimates the label does not itself publish. Mepivacaine's plain dosing (4.4 mg/kg, 400 mg ceiling) is FDA-label, but its with-vasoconstrictor ceiling is genuinely disputed across sources — some cite 500-550 mg, and this calculator conservatively clamps at 400 mg. Ropivacaine is the outlier: its FDA label doses by block or procedure rather than a single flat adult mg/kg maximum, so any single-number ceiling for ropivacaine (including the 200 mg this tool uses) is a conservative approximation, not a label fact.
How the ceiling clamp works
Every result is the lower of two numbers: the raw weight-based math (weight × mg/kg) and the agent's absolute ceiling. When a ceiling itself has been disputed across sources — as with ropivacaine's practical ceiling or mepivacaine's with-vasoconstrictor ceiling — this calculator always clamps to the more conservative (lower) figure rather than the higher end of the cited range, and shows a hedge banner explaining the discrepancy. This mirrors standard clinical practice of dosing to the safer number when sources disagree.
Injection site and patient factors change the real safe dose
The mg/kg and ceiling figures assume a healthy adult and do not adjust for injection site, which materially affects how much drug reaches the systemic circulation. Roughly ordered from highest to lowest systemic absorption: intercostal block, caudal/epidural, brachial plexus block, then subcutaneous infiltration. Dose reduction should also be considered for elderly or debilitated patients, hepatic impairment (amide local anesthetics are hepatically metabolized), cardiac disease or conduction abnormalities, and pregnancy. A vasoconstrictor raises the ceiling specifically because it slows systemic absorption at the injection site — it does not change how much total drug the patient can tolerate elsewhere in the body.
Recognizing LAST and why bupivacaine is treated with extra caution
Early signs of local anesthetic systemic toxicity include perioral numbness, tinnitus, and a metallic taste, progressing to seizures and, in severe cases, cardiovascular collapse. Treatment is 20% lipid emulsion (Intralipid) alongside standard resuscitation. Bupivacaine carries a particular caution because its cardiotoxic effects can precede or coincide with the central nervous system warning signs, making early recognition harder and resuscitation more difficult — this is part of why its per-kilogram ceiling is proportionally lower than lidocaine's.
Never sum doses across agents
This calculator evaluates exactly one agent at a time and does not track or add up doses if more than one local anesthetic is used in the same patient or procedure. Local anesthetics' systemic toxic effects are additive — if two agents are combined (for example, a field block topped up with a different agent), the combined LAST risk must be assessed by a clinician rather than approximated by adding this tool's outputs together.
What this calculator does not do
This tool does the ceiling arithmetic only. It cannot verify that the selected agent, route, or vasoconstrictor combination is appropriate for a given patient or procedure, does not account for renal or hepatic impairment beyond a general caution, and does not replace a pharmacist's or prescriber's review. For clinical/educational reference only. Not a substitute for clinical judgment. Verify all doses with a pharmacist or current prescribing information before administering.